Diabetes


  • A white, round device is stuck on a person's arm below their sleeve.
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    4 diabetes tech execs on the future of multi-analyte glucose sensors

    Executives with Abbott, PercuSense and Biolinq spoke with MedTech Dive about what’s next with multi-analyte sensor technology.

    By June 22, 2026
  • A person playing pickleball wears a circular patch on their upper arm.
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    In a first, Dexcom’s OTC glucose sensor is cleared for kids

    The Stelo over-the-counter glucose monitor can now be used by children as young as two years.

    By June 15, 2026
  • Boston Scientific's Farapulse pulsed field ablation device. Explore the Trendline
    Image attribution tooltip
    Permission granted by Boston Scientific
    Image attribution tooltip
    Trendline

    New medical devices are reshaping the medtech industry

    From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.

    By MedTech Dive staff
  • A person sits in front of a plate of food, holding a smartphone. They're wearing a patch on their left arm.
    Image attribution tooltip
    Courtesy of Insulet Corp.
    Image attribution tooltip

    Top medtech stories from ADA’s Scientific Sessions

    Dexcom, Abbott, MiniMed and Insulet featured upcoming technologies at the American Diabetes Association’s annual event. Catch up on news coming out of the conference.

    By June 12, 2026
  • A person runs in a soccer field wearing two white devices taped to their upper arms.
    Image attribution tooltip
    Courtesy of Insulet
    Image attribution tooltip

    Why Insulet thinks its fully closed loop system will stand apart from rivals

    Chief Medical Officer Trang Ly said the system, which allows people to manage Type 2 diabetes without bolusing, will be “completely different” than those being developed by MiniMed and Tandem Diabetes Care.

    By June 11, 2026
  • A person looks at a smartwatch while walking past packaged produce.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    MiniMed is in the lead as diabetes tech firms focus on ‘fully closed loop’ systems, exec says

    Ali Dianaty, MiniMed’s chief product and technology officer, believes the company is “clearly ahead” of the competition in developing automated insulin delivery systems that don’t require meal announcements.

    By June 9, 2026
  • A person smiles and holds a spoon. A white patch is on their right upper arm.
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    Dexcom bolsters evidence for glucose sensors for Type 2 diabetes

    New study results could lead to better insurance coverage of the devices for people who don’t take insulin, a researcher said.

    By June 9, 2026
  • A person walks in a forest with a square device taped to their thigh.
    Image attribution tooltip
    Courtesy of Tandem Diabetes Care
    Image attribution tooltip

    3 takeaways from ADA

    Tandem Diabetes Care, Insulet and Dexcom all presented data over the weekend at the American Diabetes Association’s Scientific Sessions.

    By June 8, 2026
  • A person playing pickleball wears a circular patch on their upper arm.
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    Dexcom buys Nutrisense; Insulet rolls out patch pump update

    In the lead-up to the American Diabetes Association’s Scientific Sessions, Dexcom announced an acquisition and Insulet improved the software for its latest patch pump.

    By June 5, 2026
  • A person holds up their shirt  to show a patch that says "Dexcom G6" on their stomach. They're holding a black, square device with a tube.
    Image attribution tooltip
    Spencer Platt via Getty Images
    Image attribution tooltip
    Deep Dive

    Diabetes tech companies are racing toward ‘fully closed loop’ devices. But automation comes with trade-offs.

    Insulet, MiniMed and Tandem Diabetes Care are all working on systems to take meal announcements out of diabetes management.

    By June 4, 2026
  • A person sits at a table with food, wearing a pink, rectangular device attached to a striped dress.
    Image attribution tooltip
    Courtesy of MiniMed
    Image attribution tooltip

    MiniMed expands Abbott partnership to add dual glucose-ketone sensor

    In its first earnings call, the newly independent diabetes tech firm said it was transforming its product portfolio, with plans that include a patch pump and an algorithm that doesn’t require meal announcements.

    By June 3, 2026
  • From left to right: A white, rectangular device that says "EO," a black device with a screen that says "EOWatch," and a smartphone.
    Image attribution tooltip
    Courtesy of EOFlow
    Image attribution tooltip

    Court overturns Insulet’s $59M trade secret verdict against EOFlow

    The U.S. appeals court ruled that Insulet filed the lawsuit too late, considering when it should have learned of the trade secret concerns.

    By June 1, 2026
  • A white, round device is stuck on a person's arm below their sleeve.
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Abbott receives CE mark for dual glucose-ketone sensor

    Abbott’s first dual-analyte sensor comes as competitors are working to develop their own versions of the technology.

    By May 27, 2026
  • A person runs in a soccer field wearing two white devices taped to their upper arms.
    Image attribution tooltip
    Courtesy of Insulet
    Image attribution tooltip

    Insulet recalls 7M patch pumps due to leak risk

    The recall is Insulet’s second this year related to tears in the device tubing. So far, 24 serious adverse events have been reported.

    By May 27, 2026
  • The Dexcom G7 Continuous Glucose Monitoring (CGM) System
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    Dexcom warns of scrapped glucose sensors being resold

    Dexcom has identified two lots of G7 sensors that have been stolen, sold and used by customers.

    By Updated May 27, 2026
  • A rectangular, plastic device sits on an adhesive patch.
    Image attribution tooltip
    Courtesy of Beta Bionics
    Image attribution tooltip

    Beta Bionics to launch its first insulin patch pump to compete with Insulet

    The device called Mint, which would work with the company’s adaptive insulin dosing algorithm, is expected to debut in the first half of 2027.

    By May 26, 2026
  • Professional photo of Dev Kurdikar
    Image attribution tooltip
    Permission granted by Embecta
    Image attribution tooltip

    Embecta closes Owen Mumford acquisition for up to $201M

    Embecta bought the company, which has an auto-injector platform, to expand outside of diabetes care.

    By May 18, 2026
  • Professional photo of Jake Leach
    Image attribution tooltip
    Permission granted by Dexcom
    Image attribution tooltip

    Dexcom to add 2 board directors with activist investor Elliott

    CEO Jake Leach also discussed the company’s plans for its G8 glucose sensor, dual-analyte sensing and Medicare coverage at an investor day.

    By May 15, 2026
  • A person walks in a forest with a square device taped to their thigh.
    Image attribution tooltip
    Courtesy of Tandem Diabetes Care
    Image attribution tooltip

    Tandem to file tubeless insulin pump with FDA this quarter

    The new version of Tandem’s Mobi pump would be the diabetes technology company’s first tubeless device.

    By May 8, 2026
  • A person sits in front of a plate of food, holding a smartphone. They're wearing a patch on their left arm.
    Image attribution tooltip
    Courtesy of Insulet Corp.
    Image attribution tooltip

    Insulet raises revenue expectations for 2026

    CEO Ashley McEvoy also shared an update on the company’s recent recall of insulin patch pumps.

    By May 6, 2026
  • A person runs in a soccer field wearing two white devices taped to their upper arms.
    Image attribution tooltip
    Courtesy of Insulet
    Image attribution tooltip

    Insulet starts study of closed loop insulin delivery system

    Indicated for people with Type 2 diabetes, the system would be Insulet’s first fully automated device for insulin delivery.

    By May 4, 2026
  • Two black, rounded devices next to each other give the same reading of 102 mg/dL.
    Image attribution tooltip
    Courtesy of Trividia Health
    Image attribution tooltip

    FDA advises users of Trividia glucometer to switch to alternatives

    The potential for error code confusion to cause delayed or improper treatment led the FDA to recommend users transition to other blood glucose meters.

    By April 30, 2026
  • A person walks in a forest with a square device taped to their thigh.
    Image attribution tooltip
    Courtesy of Tandem Diabetes Care
    Image attribution tooltip

    Tandem recalls Mobi insulin pumps over software malfunction

    A malfunction may cause insulin delivery to stop. Tandem instructed users to update their pump software as soon as possible.

    By April 22, 2026
  • A person sits at a table with food, wearing a pink, rectangular device attached to a striped dress.
    Image attribution tooltip
    Courtesy of MiniMed
    Image attribution tooltip

    MiniMed posts double-digit sales growth, widening net loss

    New glucose sensors and a partnership with Abbott are expected to drive sales growth at MiniMed, BTIG analyst Marie Thibault wrote.

    By April 21, 2026
  • A rectangular, metallic device on a catheter sites next to three nickels.
    Image attribution tooltip
    Permission granted by Glucotrack
    Image attribution tooltip

    Glucotrack plans US trial of implantable glucose monitor this year

    Glucotrack plans to file for an investigational device exemption in the second quarter, with hopes of starting a trial in the second half of 2026.

    By March 27, 2026
  • A person sits at a table with food, wearing a pink, rectangular device attached to a striped dress.
    Image attribution tooltip
    Courtesy of MiniMed
    Image attribution tooltip

    Medtronic lowers earnings forecast after MiniMed IPO

    The timing of the initial public offering and the clearance of a new insulin pump are expected to affect Medtronic’s results for its 2026 fiscal year.

    By March 25, 2026